{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T10:50:08Z","timestamp":1783680608844,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T00:00:00Z","timestamp":1710201600000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.numecd.2024.03.015","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T07:58:05Z","timestamp":1710316685000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9249-118X","authenticated-orcid":false,"given":"Chiara","family":"Bima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6930-7073","authenticated-orcid":false,"given":"Mirko","family":"Parasiliti-Caprino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6783-6588","authenticated-orcid":false,"given":"Francesca","family":"Rumbolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Ponzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4901-4764","authenticated-orcid":false,"given":"Iacopo","family":"Gesmundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Nonnato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fornengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0500-193X","authenticated-orcid":false,"given":"Giovanna","family":"Vaula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezio","family":"Ghigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-8369","authenticated-orcid":false,"given":"Giulio","family":"Mengozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Settanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2024.03.015_bib1","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s00726-015-2012-3","article-title":"Biosynthesis of homoarginine (hArg) and asymmetric dimethylarginine (ADMA) from acutely and chronically administered free l-arginine in humans","volume":"47","author":"Kayacelebi","year":"2015","journal-title":"Amino Acids"},{"key":"10.1016\/j.numecd.2024.03.015_bib2","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/01.ATV.0000081742.92006.59","article-title":"Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase","volume":"23","author":"Achan","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2024.03.015_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.cccn.2004.05.020","article-title":"Asymmetric dimethylarginine (ADMA) and acute vascular events","volume":"348","author":"Valkonen","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.numecd.2024.03.015_bib4","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pharmthera.2007.03.002","article-title":"The l-arginine paradox: importance of the l-arginine\/asymmetrical dimethylarginine ratio","volume":"114","author":"Bode-B\u00f6ger","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.numecd.2024.03.015_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0008-6363(99)00162-5","article-title":"Biological significance of endogenous methylarginines that inhibit nitric oxide synthases","volume":"43","author":"Leiper","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.numecd.2024.03.015_bib6","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.phrs.2009.07.016","article-title":"Role of the PRMT-DDAH-ADMA axis in the regulation of endothelial nitric oxide production","volume":"60","author":"Pope","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.numecd.2024.03.015_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1681\/ASN.2005101119","article-title":"Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease","volume":"17","author":"Bode-B\u00f6ger","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2024.03.015_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.99.9.1141","article-title":"Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis","volume":"9","author":"Miyazaki","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2024.03.015_bib9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1161\/01.CIR.0000126823.07732.D5","article-title":"Asymmetrical dimethylarginine: the Uber marker?","volume":"1009","author":"Cooke","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2024.03.015_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2005.05.009","article-title":"Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age?","volume":"46","author":"Kielstein","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2024.03.015_bib11","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00004872-199715080-00015","article-title":"Nitric oxide synthase inhibitors and hypertension in children and adolescents","volume":"15","author":"Goonasekera","year":"1997","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2024.03.015_bib12","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0002-9149(01)02063-X","article-title":"Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus","volume":"88","author":"Abbasi","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2024.03.015_bib13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.CIR.98.18.1842","article-title":"Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction its role in hypercholesterolemia","volume":"98","author":"B\u00f6ger","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2024.03.015_bib14","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","article-title":"Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine","volume":"108","author":"St\u00fchlinger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2024.03.015_bib15","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2005.05.002","article-title":"Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease","volume":"184","author":"Wang","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.03.015_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2143\/AC.63.1.2025329","article-title":"Asymmetrical dimethylarginine level in atrial fibrillation","volume":"63","author":"Cengel","year":"2008","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.numecd.2024.03.015_bib17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1523-1755.2002.00437.x","article-title":"Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients","volume":"62","author":"Zoccali","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2024.03.015_bib18","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/HYPERTENSIONAHA.108.120352","article-title":"Endogenous nitric oxide synthase inhibitors, arterial hemodynamics, and subclinical vascular disease: the PREVENCION study","volume":"52","author":"Chirinos","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2024.03.015_bib19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/00365599.2011.630013","article-title":"Is plasma symmetric dimethylarginine a suitable marker of renal function in children and adolescents?","volume":"46","author":"Wasilewska","year":"2012","journal-title":"Scand J Urol Nephrol"},{"issue":"5","key":"10.1016\/j.numecd.2024.03.015_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096875","article-title":"Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based Study of Health in Pomerania","volume":"9","author":"Schwedhelm","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.numecd.2024.03.015_bib21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/toxins9030092","article-title":"Toxic dimethylarginines: asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA)","volume":"9","author":"Tain","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.numecd.2024.03.015_bib22","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2024.03.015_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/003693305700200504","article-title":"Cerebral vascular accidents in patients over the age of 60: II. Prognosis","volume":"2","author":"Rankin","year":"1957","journal-title":"Scot Med J"},{"key":"10.1016\/j.numecd.2024.03.015_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2006.09.023","article-title":"An overview of plasma concentrations\u00a0of asymmetric dimethylarginine (ADMA) in health and\u00a0disease\u00a0and in clinical studies: methodological considerations","volume":"851","author":"Horowitz","year":"2007","journal-title":"J Chromatogr, B: Anal Technol Biomed Life Sci"},{"key":"10.1016\/j.numecd.2024.03.015_bib25","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0735-1097(96)00394-4","article-title":"Aging-associated endothelial dysfunction in humans is reversed by L-arginine","volume":"28","author":"Chauhan","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2024.03.015_bib26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.17219\/acem\/78360","article-title":"Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke","volume":"28","author":"Ercan","year":"2019","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.numecd.2024.03.015_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.atherosclerosis.2005.06.033","article-title":"Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population","volume":"185","author":"Wanby","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.03.015_bib28","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0021-9150(01)00444-0","article-title":"Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke","volume":"158","author":"Yoo","year":"2001","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.numecd.2024.03.015_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001833","article-title":"Asymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studies","volume":"4","author":"Willeit","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"8","key":"10.1016\/j.numecd.2024.03.015_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13558","article-title":"A systematic review of the correlation between serum asymmetric dimethylarginine, carotid atherosclerosis and ischaemic stroke","volume":"51","author":"Qin","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.numecd.2024.03.015_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.12.020","article-title":"Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke","volume":"290","author":"Nishiyama","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.numecd.2024.03.015_bib32","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1007\/s11064-009-9954-3","article-title":"Dimethylarginine levels in cerebrospinal fluid of hyperacute ischemic stroke patients are associated with stroke severity","volume":"34","author":"Brouns","year":"2009","journal-title":"Neurochem Res"},{"key":"10.1016\/j.numecd.2024.03.015_bib33","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cardfail.2012.10.011","article-title":"The L-Arginine-asymmetric dimethylarginine ratio is an independent predictor of mortality in dilated cardiomyopathy","volume":"18","author":"Anderssohn","year":"2012","journal-title":"J Card Fail"},{"key":"10.1016\/j.numecd.2024.03.015_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.atherosclerosis.2014.12.030","article-title":"Plasma arginine\/ADMA ratio as a sensitive risk marker for atherosclerosis: shimane CoHRE study","volume":"239","author":"Notsu","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.03.015_bib35","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5551\/jat.8144","article-title":"High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke","volume":"18","author":"Worthmann","year":"2011","journal-title":"J Atherosclerosis Thromb"},{"key":"10.1016\/j.numecd.2024.03.015_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/CS20110013","article-title":"Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function","volume":"122","author":"L\u00fcneburg","year":"2012","journal-title":"Clin Sci"},{"key":"10.1016\/j.numecd.2024.03.015_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.atherosclerosis.2009.06.039","article-title":"Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke","volume":"208","author":"Schulze","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2024.03.015_bib38","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00392-017-1172-4","article-title":"Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease","volume":"107","author":"Emrich","year":"2018","journal-title":"Clin Res Cardiol"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475324001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T23:39:49Z","timestamp":1712187589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475324001170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":38,"alternative-id":["S0939475324001170"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2024.03.015","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2024.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}]}}